Out-of-hospital births in the United States 2009-2014

Journal of Perinatal Medicine
Amos Grünebaum, Frank A Chervenak

Abstract

To evaluate recent trends of out-of-hospital births in the US from 2009 to 2014. We accessed data for all live births occurring in the US from the National Vital Statistics System, Natality Data Files for 2009-2014 through the interactive data tool, VitalStats. Out-of-hospital (OOH) births in the US increased from 2009 to 2014 by 80.2% from 32,596 to 58,743 (0.79%-1.47% of all live births). Home births (HB) increased by 77.3% and births in freestanding birthing centers (FBC) increased by 79.6%. In 2014, 63.8% of OOH births were HB, 30.7% were in FBC, and 5.5% were in other places, physicians offices, or clinics. The majority of women who had an OOH birth in 2014 were non-Hispanic White (82.3%). About in one in 47 non-Hispanic White women had an OOH in 2014, up from 1 in 87 in 2009. Women with a HB were older compared to hospital births (age ≥35: 21.5% vs. 15.4%), had a higher live birth order(≥5: 18.9% vs. 4.9%), 3.48% had infants <2500 g and 4.66% delivered <37 weeks' gestation. 4.34% of HB were patients with prior cesarean deliveries, 1.6% were breech, and 0.81% were twins. Since 2004 the number of women delivered out of the hospital, at home and in freestanding birthing centers has significantly increased in the US making it...Continue Reading

References

Sep 19, 2002·Maternal and Child Health Journal·David L DiGiuseppeGary E Rosenthal
Jun 18, 2005·BMJ : British Medical Journal·Kenneth C Johnson, Betty-Anne Daviss
Jul 26, 2005·Annals of Epidemiology·Terrell W ZollingerRoland E Gamache
Feb 10, 2006·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·Sally Northam, Thomas R Knapp
Sep 2, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Patricia A JanssenShoo K Lee
Jun 23, 2010·Obstetrics and Gynecology·Eugene DeclercqNaomi Stotland
Jul 6, 2010·American Journal of Obstetrics and Gynecology·Joseph R WaxJacquelyn Blackstone
Nov 16, 2012·American Journal of Obstetrics and Gynecology·Frank A ChervenakBirgit Arabin
Jan 4, 2013·Birth·Pierre Buekens, Marc J N C Keirse
Jun 25, 2013·American Journal of Obstetrics and Gynecology·Yvonne W ChengAaron B Caughey
Oct 23, 2013·Pediatrics·Frank A ChervenakRobert L Brent
Mar 26, 2014·American Journal of Obstetrics and Gynecology·Amos GrünebaumFrank A Chervenak
Apr 24, 2014·Journal of Perinatal Medicine·Amos GrünebaumFrank A Chervenak
Nov 17, 2014·Circulation·Paul S ChanArthur Kellermann
Dec 3, 2014·American Journal of Obstetrics and Gynecology·Amos GrünebaumFrank A Chervenak

❮ Previous
Next ❯

Citations

Feb 6, 2017·American Journal of Obstetrics and Gynecology·Amos GrünebaumFrank A Chervenak
Apr 7, 2018·Journal of Perinatal Medicine·Frank A Chervenak, Laurence B McCullough
Nov 20, 2016·Journal of Perinatal Medicine·Shane W WasdenHeather S Lipkind
Apr 13, 2018·Journal of Perinatal Medicine·Kelly B ZafmanStephanie H Factor
Feb 25, 2020·PloS One·Evelyne CombierCatherine Quantin
Mar 24, 2020·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Roberto C PortelaKori Brewer
May 16, 2017·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Andrea CiardulliVincenzo Berghella
Oct 21, 2020·The Journal of Perinatal & Neonatal Nursing·Elena CoupalErin Rothwell

❮ Previous
Next ❯

Methods Mentioned

BETA
cesarean section

Software Mentioned

VitalStats

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.